Clinical Trial To Evaluate Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With Chronic Kidney Disease Stage IV

Clinical trial NCT04913272 · SUSPENDED

Trial details

NCT number: NCT04913272
Sponsor: Kibow Pharma
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Kidney Disease stage4

Start date: 2021-06-24
Primary completion: 2025-09-01
Enrollment: 630

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.